"Are they really taming volatility with their bond-buying, or just jamming it into a coiled spring?"
Wall Street pay and shareholder performance don't always line up, with a few caveats.
Some view skyrocketing biotech stocks as a bubble, but hedge funds are riding optimism in the sector to monster gains—for now.
The Nikkei's relentless bull-run has raised concerns if a correction is on the pipeline. Chart analysis, however, suggests otherwise.
Despite strict water restrictions, California's water parks are still wet, fairways are still green and showering at hotels is still possible.
Inside the NYSE's renovation
Hedge fund managers are fuming at new political rhetoric against them and their huge paydays.
Those having a hard time finding growth in the U.S. economy are looking in the wrong places.
Western investors see China as a slowing giant, but local traders have used a more optimistic take to score their biggest gains in years.
Carl Icahn was feted by friend and fellow billionaire Leon Black at a charity event for skin cancer.
At a time when 8.5 million Americans still don't have jobs, some 40 percent have given up even looking.
Three of the largest U.S. banks alone collected in the first quarter more than $1.1 billion related to overdrafts.
After decades of swallowing up their smaller competitors, pressure is on for warehouse financial institutions to start divesting their businesses.
Carl Icahn's big bet on Apple is now one of the greatest trades of all time.
While the euro-dollar breakout looked like a short-term move rather than a trend change, the situation now is different and impacts long term positions.
Stocks poised for a breakdown?
Stock-picking hedge funds are finally beating low-cost equity index funds this year—here's how the best did it.
Goldman Sachs analysts believe the S&P may climb a bit higher before its ascent is over for the next 12 months.
A high-flying private investment firm known for its prescient bets on tech is losing two of its top executives.
Executives who use their time to lower their handicaps also often lower their firms' returns, a study shows.